06:48 PM, 29th Nov 2024
The Exchange has sought clarification from Lupin Ltd on November 29 2024 with reference to news appeared in www.business-standard.com dated November 29 2024 quoting Lupin shares gain 3% after USFDA approves type-2 diabetes drug; details <BR><BR>The reply is awaited.